2019-04-14, 23:50
Harvard’s immune-silent stem cell technique licensed to Sana Biotechnology
Developed through Harvard’s Blavatnik Biomedical Accelerator, an innovative immune-silent stem cell technology could lead to novel cell therapies to treat “any patient with any disease.”
https://news.harvard.edu/gazette/story/2...edium=Feed&utm_source=Syndication
Developed through Harvard’s Blavatnik Biomedical Accelerator, an innovative immune-silent stem cell technology could lead to novel cell therapies to treat “any patient with any disease.”
https://news.harvard.edu/gazette/story/2...edium=Feed&utm_source=Syndication